Diseases Overview is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
This section contains comprehensive information on neurodegenerative diseases, covering Alzheimer's disease, Parkinson's disease, ALS, frontotemporal dementia, and related disorders. These conditions share common features including progressive neuronal loss, protein aggregation, and eventual cognitive and motor impairment.[1]
Alzheimer's disease (AD) is the most common neurodegenerative disease, affecting an estimated 6.5 million Americans aged 65 and older.[2] The disease is characterized by extracellular amyloid-beta (Aβ) plaques and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein. Cognitive decline typically begins with episodic memory impairment and progresses to include language deficits, visuospatial dysfunction, and behavioral changes.[3]
Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting approximately 1 million Americans.[4] The hallmark pathological features are Lewy bodies (intracellular inclusions rich in alpha-synuclein) and loss of dopaminergic neurons in the substantia nigra pars compacta. Motor symptoms include resting tremor, bradykinesia, rigidity, and postural instability.[5]
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive motor neuron disease affecting both upper and lower motor neurons. Most cases are sporadic, while approximately 10-20% are familial. The disease leads to progressive muscle weakness, respiratory failure, and typically death within 2-5 years of onset.[6]
Frontotemporal dementia (FTD) encompasses a spectrum of disorders characterized by progressive degeneration of the frontal and temporal lobes. The behavioral variant FTD presents with personality changes and social conduct deficits, while primary progressive aphasia affects language function.[7]
Neurodegenerative diseases can be classified by their characteristic protein aggregates:
| Proteinopathy | Associated Diseases |
|---|---|
| Amyloid-beta | Alzheimer's disease |
| Tau | AD, PSP, CBD, Pick's disease |
| Alpha-synuclein | PD, MSA, Lewy body dementia |
| TDP-43 | ALS, FTD |
| FUS | ALS, FTD |
| Huntingtin | Huntington's disease |
| Prion protein | CJD, fatal insomnia |
Neurodegenerative diseases represent a growing public health challenge due to aging populations worldwide:[8]
The economic burden exceeds $350 billion annually for Alzheimer's disease alone in the US.[2:1]
While each disease has distinct features, common pathogenic mechanisms include:[9]
Gitler AD, et al. Molecular biology and pathogenesis of neurodegenerative disease. Nature Reviews Genetics. 2018. ↩︎
2023 Alzheimer's Disease Facts and Figures. Alzheimer's & Dementia. Alzheimer's & Dementia. 2023. ↩︎ ↩︎
Scheltens P, et al. Alzheimer's disease. The Lancet. 2021. ↩︎
Parkinson's Foundation. Parkinson's Disease Statistics. ↩︎
Kalia LV, Lang AE. Parkinson's disease. The Lancet. 2015. ↩︎
Hardiman O, et al. Amyotrophic lateral sclerosis. Nature Reviews Disease Primers. 2017. ↩︎
Rascovsky K, et al. Behavioral variant frontotemporal dementia. Brain. 2011. ↩︎
GBD 2019 Dementia Forecasting Collaborators. Projection of the global burden of Alzheimer's disease. The Lancet Psychiatry. 2019. ↩︎
Duggan MR, et al. Shared mechanisms across the major neurodegenerative diseases. Prion. 2021. ↩︎